Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Orsolya Pipek

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Scientific Reports|January 15, 2024
Biologically informed deep learning for explainable epigenetic clocksAurel Prosz, Orsolya Pipek, Judit Börcsök, et al.
Cancers|March 29, 2023
The Driverless Triple-Wild-Type (BRAF, RAS, KIT) Cutaneous Melanoma: Whole Genome Sequencing DiscoveriesOrsolya Pipek, Laura Vizkeleti, Viktória Doma, et al.
Frontiers in Immunology|September 25, 2020
FcRn Overexpression Expands Diversity of the Humoral Immune Response in bFcRn Transgenic MiceBence Szikora, Anita Marx, Péter K Jani, et al.
NPJ Precision Oncology|June 20, 2025
Polymerase theta expression is correlated with proliferative capacity but not with DNA repair deficiency status in solid tumorsZsofia Sztupinszki, Regina Fiam, Orsolya Pipek, et al.
Pathology Oncology Research : POR|August 25, 2023
Claudin expression in pulmonary adenoid cystic carcinoma and mucoepidermoid carcinomaMarton Gyulai, Tunde Harko, Katalin Fabian, et al.
Basic & Clinical Pharmacology & Toxicology|August 24, 2017
Renal Impairment Hampers Bisphosphonate Treatment in a Quarter of Lung Cancer Patients with Bone MetastasisKatalin Fábián, Rita Puskás, Tímea Kakuk, et al.
G3 (Bethesda, Md.)|September 18, 2014
The genome of the chicken DT40 bursal lymphoma cell lineJános Molnár, Ádám Póti, Orsolya Pipek, et al.
Basic & Clinical Pharmacology & Toxicology|July 22, 2017
Renal Impairment Hampers Bisphosphonate Treatment in a Quarter of Lung Cancer Patients with Bone MetastasisKatalin Fábián, Rita Puskás, Tímea Kakuk, et al.
International Journal of Cancer|January 30, 2019
The genomic imprint of cancer therapies helps timing the formation of metastasesEszter Németh, Marcin Krzystanek, Lilla Reiniger, et al.
British Journal of Cancer|November 15, 2018
Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenograftsÁdám Póti, Kinga Berta, Yonghong Xiao, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Scientific Reports|January 15, 2024
Biologically informed deep learning for explainable epigenetic clocksAurel Prosz, Orsolya Pipek, Judit Börcsök, et al.
Cancers|March 29, 2023
The Driverless Triple-Wild-Type (BRAF, RAS, KIT) Cutaneous Melanoma: Whole Genome Sequencing DiscoveriesOrsolya Pipek, Laura Vizkeleti, Viktória Doma, et al.
Frontiers in Immunology|September 25, 2020
FcRn Overexpression Expands Diversity of the Humoral Immune Response in bFcRn Transgenic MiceBence Szikora, Anita Marx, Péter K Jani, et al.
NPJ Precision Oncology|June 20, 2025
Polymerase theta expression is correlated with proliferative capacity but not with DNA repair deficiency status in solid tumorsZsofia Sztupinszki, Regina Fiam, Orsolya Pipek, et al.
Pathology Oncology Research : POR|August 25, 2023
Claudin expression in pulmonary adenoid cystic carcinoma and mucoepidermoid carcinomaMarton Gyulai, Tunde Harko, Katalin Fabian, et al.
Basic & Clinical Pharmacology & Toxicology|August 24, 2017
Renal Impairment Hampers Bisphosphonate Treatment in a Quarter of Lung Cancer Patients with Bone MetastasisKatalin Fábián, Rita Puskás, Tímea Kakuk, et al.
G3 (Bethesda, Md.)|September 18, 2014
The genome of the chicken DT40 bursal lymphoma cell lineJános Molnár, Ádám Póti, Orsolya Pipek, et al.
Basic & Clinical Pharmacology & Toxicology|July 22, 2017
Renal Impairment Hampers Bisphosphonate Treatment in a Quarter of Lung Cancer Patients with Bone MetastasisKatalin Fábián, Rita Puskás, Tímea Kakuk, et al.
International Journal of Cancer|January 30, 2019
The genomic imprint of cancer therapies helps timing the formation of metastasesEszter Németh, Marcin Krzystanek, Lilla Reiniger, et al.
British Journal of Cancer|November 15, 2018
Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenograftsÁdám Póti, Kinga Berta, Yonghong Xiao, et al.
Pageof 4